Every price names its source
No sponsorships, referrals or clinic partnerships
EpiPen, insulin & Ozempic prices refreshed October 2026
Cost comparison only — not medical advice
Every price names its source
No sponsorships, referrals or clinic partnerships
EpiPen, insulin & Ozempic prices refreshed October 2026
Cost comparison only — not medical advice
← All Articles
Drug Prices

Xarelto Price by Country: $197 for Medicare, €23 in France

The same blood thinner, 20 mg once a day — priced from official databases in six places, with generic rivaroxaban where it is sold.

Researched with AI assistance; every figure is checked against the primary source cited on this page before publishing. How we work →

Key Takeaways

  • $197 for Medicare, $517 list in 2023 — for 2026 only. Medicare's negotiated price for a 30-day supply applies from January 1, 2026, 62% below the 2023 list price. CMS's price file ends it on December 31, 2026 and marks Xarelto as deselected.
  • US pharmacies pay about $586 for 30 tablets. That is the national average acquisition cost of the 20 mg tablet in late October 2026 (CMS NADAC, $19.53935 per tablet); the survey lists no generic 20 mg tablet, only a generic 2.5 mg.
  • Europe: about $28 to $72 for brand Xarelto for a month. Official prices for 30 tablets at ECB rates: France $28, the Netherlands $41, Switzerland $43, the UK $72 (our calculation for packs of 28).
  • Generic rivaroxaban costs a fraction. The NHS Drug Tariff pays £0.96 for 28 generic 20 mg tablets — about $1.38 for 30 days; France lists a generic at €13.25 for 30.

Xarelto Price by Country (November 2026)

Xarelto 20 mg, one tablet a day, so 30 days = 30 tablets. Each country's own official price; where the official pack has 28 tablets or the source gives a price per tablet, we convert to 30 tablets (our calculation: pack price ÷ tablets × 30). US dollars at European Central Bank reference rates of October 30, 2026. We could not verify a current US list price from the maker, so we show the 2023 list price reported by CMS.

30 days = 30 tablets of 20 mg. US: CMS negotiated price and 2023 list price (2026 fact sheet), CMS NADAC (October 28, 2026). UK: NHS dm+d and Drug Tariff (October 2026). France: BDPM official price excluding dispensing fee (September 29, 2026). Switzerland: BAG public price. Netherlands: Zorginstituut average price per pack of 28 (to November 1, 2026). Converted at ECB rates of October 30, 2026; packs of 28 scaled to 30 tablets (our calculation).
CountryOfficial price30 days in US dollarsWhat a patient typically pays
🇺🇸 United States (Medicare)$197 negotiated price per 30-day supply, Jan 1 – Dec 31, 2026; 2023 list price $517 (CMS)$197Depends on the Part D plan
🇺🇸 United States (pharmacy cost)$19.53935 per 20 mg tablet (CMS NADAC, Oct 28, 2026)$586Depends on insurance
🇬🇧 United Kingdom£50.40 for 28 tablets (NHS price); generic rivaroxaban £0.96 for 28 (Drug Tariff, from Oct 1, 2026)$72 · generic $1.38£9.90 per item in England; free in Scotland, Wales and Northern Ireland
🇫🇷 France€23.25 for 28 tablets; generic €13.25 for 30 (official prices excluding dispensing fee)$28 · generic $1535% of the price unless a complementary insurer covers it (65% reimbursed)
🇨🇭 SwitzerlandCHF 33.40 for 28 tablets (public price); generics CHF 32.00 for 28$43 · generic $4210% share after the annual deductible
🇦🇹 Austria€41.35 for 28 tablets; generic rivaroxaban (Zentiva) €8.60 for 28 tablets (social-insurance prices excl. VAT)$49 · generic $10€7.55 prescription fee per pack; Xarelto needs insurer approval first, generics do not
🇳🇱 Netherlands€34.65 for 28 tablets (average pharmacy price)$41Reimbursed under conditions; counts toward the annual deductible
🇩🇪 GermanyNo statutory price ceiling (Festbetrag) for rivaroxaban 20 mg — the list covers only 2.5 mg—€5–€10 co-payment per pack (10%, min. €5, max. €10)

We compare prices; we do not recommend where to buy medicine. Whether to take or switch an anticoagulant is a decision for your doctor.

What the Numbers Mean

Three US prices, three different things

The $517 is the 2023 list price CMS used as its reference. The $197 is the price Medicare negotiated under the Inflation Reduction Act; it took effect on January 1, 2026, 62% below that list price, according to CMS. CMS's maximum-fair-price file of November 2, 2026 ends that price on December 31, 2026 and marks Xarelto as deselected. The $586 is the national average that pharmacies paid to buy 30 tablets in late October 2026 (NADAC). Pharmacies that dispense Xarelto to Medicare patients are refunded the difference by the drug maker afterward (CMS).

Generic rivaroxaban: sold in Europe, not yet in the US survey at 20 mg

Europe's official lists already carry generic 20 mg tablets: £0.96 for 28 in the NHS Drug Tariff, €13.25 for 30 in France, CHF 32.00 for 28 in Switzerland. The US national pharmacy-price survey (NADAC, October 28, 2026) shows a generic only for the 2.5 mg tablet.

Germany: no price ceiling for 20 mg yet

The German statutory price-ceiling (Festbetrag) list of November 1, 2026 still includes rivaroxaban only at 2.5 mg. On January 13, 2026, the Federal Joint Committee opened a consultation on a reference-price group for direct oral anticoagulants. Insured patients pay the usual co-payment of 10% of the price, at least €5 and at most €10 per pack; from 2027 the limits rise to €7.50 and €15.

Frequently Asked Questions

How much does Xarelto cost in the US compared with other countries?

Medicare pays a negotiated $197 for a 30-day supply of Xarelto from January 1 to December 31, 2026; the 2023 list price was $517 (CMS). US pharmacies pay about $586 for 30 tablets of 20 mg (CMS NADAC, October 28, 2026). Official prices for brand Xarelto elsewhere: €23.25 for 28 tablets in France, €34.65 in the Netherlands, CHF 33.40 in Switzerland and £50.40 in the UK — roughly $28 to $72 for 30 tablets at ECB rates.

Is there a generic Xarelto (rivaroxaban)?

Yes in Europe. The UK's Drug Tariff lists generic rivaroxaban 20 mg at £0.96 for 28 tablets (from October 1, 2026), France at €13.25 for 30 and Switzerland at CHF 32.00 for 28. In the US, the national pharmacy-price survey (NADAC, October 28, 2026) lists a generic only for the 2.5 mg tablet, not for 20 mg.

Why is Medicare's price lower than what pharmacies pay?

The $197 is Medicare's negotiated price for a 30-day supply. NADAC (about $586 for 30 tablets) measures what pharmacies pay to acquire the drug; under the negotiation program the drug maker refunds pharmacies the difference afterwards (CMS), so the two numbers measure different things.

Does Medicare's negotiated price continue in 2027?

No, according to CMS's maximum-fair-price file of November 2, 2026: the $197 price for Xarelto runs from January 1 to December 31, 2026 and the drug is marked as deselected. What Medicare patients pay in 2027 will depend on their Part D plan.

What do patients pay for Xarelto?

In England each prescription item costs £9.90. France reimburses 65% of the official price. In Germany statutory insurance covers it with a co-payment of 10% of the price, at least €5 and at most €10 per pack. In Switzerland insured patients pay a 10% share after their deductible, and in the Netherlands it is reimbursed under conditions and counts toward the annual deductible. In the US it depends on the insurance plan.

What does Xarelto cost in Germany?

Germany has no statutory price ceiling (Festbetrag) for rivaroxaban 20 mg: the list of November 1, 2026 still includes only the 2.5 mg tablet. In January 2026 the Federal Joint Committee (G-BA) opened a consultation on a reference-price group for direct oral anticoagulants. We found no current official pharmacy price that is freely published, so we show none.

Sources

  1. CMS — Negotiated prices for initial price applicability year 2026 (fact sheet): Xarelto $197 negotiated price, $517 list price (2023), 30-day supply, 62% lower
  2. CMS — Selected drug list and maximum fair price data file (November 2, 2026): Xarelto price effective January 1 to December 31, 2026, update type “Deselect”
  3. CMS — Medicare Drug Price Negotiation Program: final guidance and effectuation of the negotiated price (refunds from drug makers to pharmacies)
  4. CMS — NADAC (National Average Drug Acquisition Cost), as of October 28, 2026: Xarelto 20 mg tablet $19.53935; generic rivaroxaban listed only at 2.5 mg ($0.6265)
  5. NHS dm+d — Xarelto 20 mg tablets, 28: NHS indicative price £50.40 (since December 1, 2015)
  6. NHS dm+d — Rivaroxaban 20 mg tablets, 28: Drug Tariff price £0.96 (from October 1, 2026)
  7. NHS Business Services Authority — prescription charge £9.90 per item (England)
  8. Base de données publique des médicaments — Xarelto 20 mg, 28 tablets: €23.25 excluding dispensing fee, 65% reimbursed (updated September 29, 2026)
  9. Base de données publique des médicaments — Rivaroxaban Viatris 20 mg, 30 tablets: €13.25 excluding dispensing fee, 65% reimbursed
  10. Federal Office of Public Health (BAG) — Spezialitätenliste: Xarelto 20 mg, 28 tablets, public price CHF 33.40; generics CHF 32.00; cost share 10%
  11. Austrian social insurance (Dachverband) — Erstattungskodex monthly data, Nov 2026: Xarelto 20 mg Filmtabl. €41.35; Rivaroxaban "Zentiva" 20 mg Filmtabl. €8.60 (social-insurance price excl. VAT; Xarelto chief-physician approval (RE1), generics green box)
  12. oesterreich.gv.at — prescription fee (Rezeptgebühr) €7.55 per pack since January 1, 2026
  13. Zorginstituut Nederland — Medicijnkosten.nl: Xarelto 20 mg (EU/1/08/472/018), average price €34.65 per pack, reimbursed under conditions (updated to November 1, 2026)
  14. European Medicines Agency — Xarelto product information: EU/1/08/472/018 = 28 film-coated tablets
  15. BfArM / GKV-Spitzenverband — Festbetrag list as of November 1, 2026 (rivaroxaban only at 2.5 mg; unchanged from October 15)
  16. Federal Joint Committee (G-BA) — consultation on a reference-price group for direct oral anticoagulants, January 13, 2026
  17. European Central Bank — reference rates, October 30, 2026 (1 US dollar = €0.89509 = £0.74633 = CHF 0.82295)

Wellness Vision Editorial Policy

Wellness Vision does not sell medicine, recommend pharmacies or suppliers, or take payments from drug makers. Every price above comes from the official source cited; conversions and per-30-tablet figures are our own calculations, shown with their formula. This is a cost comparison, not medical advice.

You shouldn't have to go broke to feel whole.